Financial Performance3Q revenue/case shipments missed expectations and management guided 4Q below expectations, which is not encouraging and likely sends shares lower.
Market DemandManagement provided 4Q24 revenue guidance below consensus as macro dynamics continue to negatively impact the clear aligner market, particularly in the US.
Valuation And Market ExpectationsAlign Technology's shares are down 23% year-to-date with a more recent 19% deterioration in October, amidst low expectations and disappointing volume guidance.